首页> 外文期刊>Theranostics >Increased recruitment of endogenous stem cells and chondrogenic differentiation by a composite scaffold containing bone marrow homing peptide for cartilage regeneration
【24h】

Increased recruitment of endogenous stem cells and chondrogenic differentiation by a composite scaffold containing bone marrow homing peptide for cartilage regeneration

机译:包含骨髓归巢肽的复合支架用于软骨再生,可增加内源性干细胞的募集和软骨分化

获取原文
       

摘要

Even small cartilage defects could finally degenerate to osteoarthritis if left untreated, owing to the poor self-healing ability of articular cartilage. Stem cell transplantation has been well implemented as a common approach in cartilage tissue engineering but has technical complexity and safety concerns. The stem cell homing-based technique emerged as an alternative promising therapy for cartilage repair to overcome traditional limitations. In this study, we constructed a composite hydrogel scaffold by combining an oriented acellular cartilage matrix (ACM) with a bone marrow homing peptide (BMHP)-functionalized self-assembling peptide (SAP). We hypothesized that increased recruitment of endogenous stem cells by the composite scaffold could enhance cartilage regeneration. Methods: To test our hypothesis, in vitro proliferation, attachment and chondrogenic differentiation of rabbit mesenchymal stem cells (MSCs) were tested to confirm the bioactivities of the functionalized peptide hydrogel. The composite scaffold was then implanted into full-thickness cartilage defects on rabbit knee joints for cartilage repair, in comparison with microfracture or other sample groups. Stem cell recruitment was monitored by dual labeling with CD29 and CD90 under confocal microcopy at 1 week after implantation, followed by chondrogenic differentiation examined by qRT-PCR. Repaired tissue of the cartilage defects was evaluated by histological and immunohistochemistry staining, microcomputed tomography (micro-CT) and magnetic resonance imaging (MRI) at 3 and 6 months post-surgery. Macroscopic and histological scoring was done to evaluate the optimal in vivo repair outcomes of this composite scaffold. Results: The functionalized SAP hydrogels could stimulate rabbit MSC proliferation, attachment and chondrogenic differentiation during in vitro culture. At 7 days after implantation, increased recruitment of MSCs based on CD29+ /CD90+ double-positive cells was found in vivo in the composite hydrogel scaffold, as well as upregulation of cartilage-associated genes (aggrecan, Sox9 and type II collagen). After 3 and 6 months post-surgery, the articular cartilage defect in the composite scaffold-treated group was fully covered with cartilage-like tissue with a smooth surface, which was similar to the surrounding native cartilage, according to the results of histological and immunohistochemistry staining, micro-CT and MRI analysis. Macroscopic and histological scoring confirmed that the quality of cartilage repair was significantly improved with implantation of the composite scaffold at each timepoint, in comparison with microfracture or other sample groups. Conclusion: Our findings demonstrated that the composite scaffold could enhance endogenous stem cell homing and chondrogenic differentiation and significantly improve the therapeutic outcome of chondral defects. The present study provides a promising approach for in vivo cartilage repair without cell transplantation. Optimization of this strategy may offer great potential and benefits for clinical application in the future.
机译:由于关节软骨的自愈能力差,即使不加以治疗,即使是小的软骨缺损也可能最终退化为骨关节炎。干细胞移植已作为软骨组织工程中的常用方法得到了很好的实现,但存在技术复杂性和安全性问题。基于干细胞归巢的技术作为克服传统局限性的软骨修复替代疗法有望出现。在这项研究中,我们通过将定向的脱细胞软骨基质(ACM)与骨髓归巢肽(BMHP)功能化的自组装肽(SAP)相结合,构建了复合水凝胶支架。我们假设复合支架增加内源性干细胞的募集可以增强软骨再生。方法:为了验证我们的假设,测试了兔间充质干细胞(MSC)的体外增殖,粘附和软骨分化,以证实功能化肽水凝胶的生物活性。与微骨折或其他样品组相比,该复合支架随后被植入兔膝关节全厚度的软骨缺损中以修复软骨。植入后1周,在共聚焦显微镜下通过CD29和CD90双重标记监测干细胞募集,然后通过qRT-PCR检查软骨分化。在手术后3个月和6个月,通过组织学和免疫组织化学染色,微型计算机断层扫描(micro-CT)和磁共振成像(MRI)评估软骨缺损的修复组织。进行宏观和组织学评分以评估该复合支架的最佳体内修复结果。结果:功能化的SAP水凝胶在体外培养过程中可刺激兔骨髓间充质干细胞增殖,附着和软骨分化。植入后第7天,在复合水凝胶支架中发现了体内基于CD29 + / CD90 +双阳性细胞的MSC募集增加,以及与软骨相关的基因(aggrecan,Sox9和II型胶原)上调。术后3个月和6个月,根据组织学和免疫组织化学结果,复合支架治疗组的关节软骨缺损被表面光滑的软骨样组织完全覆盖,该表面类似于周围的天然软骨。染色,显微CT和MRI分析。宏观和组织学评分证实,与微骨折或其他样品组相比,在每个时间点植入复合支架可显着改善软骨修复的质量。结论:我们的发现表明复合支架可以增强内源性干细胞归巢和软骨分化,并显着改善软骨缺损的治疗效果。本研究提供了一种无需细胞移植的体内软骨修复的有前途的方法。该策略的优化可能为将来的临床应用提供巨大的潜力和益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号